Product Image

Contributor Information

  • Name Andrew Crowe
  • Institute Curtin University

Tool Details

  • Tool name: CLEFF4 cell line
  • Tool type: Cell Lines
  • Parental cell line: Caco-2
  • Organism: Human
  • Tissue: Colon
  • Model: Mutant
  • Description: Pharmaceutical drug development requires drug targets to be characterised against efflux transporters. An example is P-glycoprotein (P-gp) which prevents the uptake and trans-cellular transport of hundreds of drug groups. The standard model is to use Caco-2 cells as these can be induced to express high concentrations of P-gp. Said tight junction model can approximate the role of P-gp at the barrier sites in the body including the gastrointestinal tract and also the blood-brain-barrier. There are however limitations to the Caco-2 cell line, including taking 24 days to develop the characteristics required for P-gp-mediated efflux modelling. Further, other efflux proteins including BCRP and MRP2 are often present in Caco-2 cells, which add extra variables when characterising specific P-gp mediated effects. The CLEFF4 cell line is ready to use in just 5 days and has a 3-fold higher expression of P-gp cells at 5-7 days compared to Caco-2 cells at day 21, expressing no more MRP2 and less BCRP than the parent Caco-2 cells. This is a faster, more specific model for P-gp assays offering cost and time savings and which has reduced medium requirement (one can use standard not accelerated media).
  • Research area: Drug development

  • For Research Use Only

Target Details

  • Target: CLEFF4

Application Details

Handling

  • Format: Frozen
  • Shipping conditions: Dry ice

Documentation

References